Rituxan in the treatment of cold agglutinin disease.
Lee
E J
EJ
Kueck
B
B
D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000209:etiology / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D016393:Lymphoma, B-Cell / Q000150:complications / Q000628:therapy*; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D000069283:Rituximab; D003520:Cyclophosphamide; D011241:Prednisone